EN
抗体药类似物
Research Grade Conatumumab
All
  • CatalogTD-HT348036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsAMG655,TRAIL-R2mAb,XG1-048vw,CAS:896731-82-1
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Conatumumab


Catalog No. TD-HT348036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target TRAILR2, TRAIL-R2, Death receptor 5, CD262, DR5, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9, TRAIL receptor 2, TRICK2, TNFRSF10B, KILLER, TNF-related apoptosis-inducing ligand receptor 2
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession O14763
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names AMG655,TRAIL-R2mAb,XG1-048vw,CAS:896731-82-1
Background Conatumumab (AMG 655) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) (Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5). Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers. .
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HT348036_1.jpg
Bioactivity
 
Detects CD262/TNFRSF10B/TRAIL-R2/DR5 in indirect ELISAs.